APPLICATION
ANDA065083
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-20
LATEST ACTION
2008-04-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CEFPODOXIME PROXETILDiscontinued
CEFPODOXIME PROXETIL EQ 200MG BASE · TABLET · ORAL
CEFPODOXIME PROXETILDiscontinued
CEFPODOXIME PROXETIL EQ 100MG BASE · TABLET · ORAL
Approval history
2008-04-25Labeling · Supplement 10AP
2004-07-12Labeling · Supplement 2AP
2003-08-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.